Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Germline Pathogenic Variants in BRCA1 and BRCA2: Malignancies Beyond Female Breast and Ovarian Cancers.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 May 2022

Lieberman Sari, Goldvaser Hadar, Levy-Lahad Ephrat

Abstract excerpt

No abstract is available from the source.

Topics

Join the communities discussing this publication.

BRCA1 Protein
BRCA2 Protein
Breast Neoplasms
Genetic Predisposition to Disease
Germ Cells
Germ-Line Mutation
Ovarian Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35286153
DOI: 10.1200/JCO.22.00003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Germline Pathogenic Variants in BRCA1 and BRCA2: Malignancies Beyond Female Breast and Ovarian Cancers.PMID 35286153Read ↗

Emerging cancer risks in BRCA2 pathogenic germline variant carriers.Semantic proximity Read ↗

BRCA1 and BRCA2 - update and implications on the genetics of breast cancer: a clinical perspective.Semantic proximity Read ↗

BRCA-associated cancer risk: molecular biology and clinical practice.Semantic proximity Read ↗

The role of BRCA1/2 in hereditary and familial breast and ovarian cancersSemantic proximity Read ↗

Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline VariantsSemantic proximity Read ↗

[Germline mutations and breast cancer risk].Semantic proximity Read ↗

Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).Semantic proximity Read ↗

Germline Genetic Testing for Hereditary Breast and Ovarian Cancer: Current Concepts in Risk Evaluation.Semantic proximity Read ↗

Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelinesSemantic proximity Read ↗

Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants.Semantic proximity Read ↗

BRCA1-BRCA2 mutation analysis results in 910 individuals: Mutation distribution and 8 novel mutations.Semantic proximity Read ↗

BRCA1 and BRCA2.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.